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The rate of teenage pregnancy in the United States is higher than in other developed
nations. Teenage births result in substantial costs, including public assistance, health
care costs, and income losses due to lower educational attainment and reduced
earning potential.
METHODS

The Contraceptive CHOICE Project was a large prospective cohort study designed to
promote the use of long-acting, reversible contraceptive (LARC) methods to reduce
unintended pregnancy in the St. Louis region. Participants were educated about
reversible contraception, with an emphasis on the benefits of LARC methods, were
provided with their choice of reversible contraception at no cost, and were followed
for 2 to 3 years. We analyzed pregnancy, birth, and induced-abortion rates among
teenage girls and women 15 to 19 years of age in this cohort and compared them
with those observed nationally among U.S. teens in the same age group.
RESULTS

Of the 1404 teenage girls and women enrolled in CHOICE, 72% chose an intrauterine device or implant (LARC methods); the remaining 28% chose another method.
During the 2008–2013 period, the mean annual rates of pregnancy, birth, and abortion among CHOICE participants were 34.0, 19.4, and 9.7 per 1000 teens, respectively.
In comparison, rates of pregnancy, birth, and abortion among sexually experienced
U.S. teens in 2008 were 158.5, 94.0, and 41.5 per 1000, respectively.
CONCLUSIONS

Teenage girls and women who were provided contraception at no cost and educated about reversible contraception and the benefits of LARC methods had rates
of pregnancy, birth, and abortion that were much lower than the national rates for
sexually experienced teens. (Funded by the Susan Thompson Buffett Foundation and
others.)
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A

lthough it has declined substantially over the past two decades, the pregnancy rate among girls and women 15 to
19 years of age remains a stubborn public health
problem. Each year, more than 600,000 teens become pregnant, and 3 in 10 teens will become
pregnant before they reach 20 years of age.1,2 Rates
are higher among black and Hispanic teens, with
4 in 10 becoming pregnant by 20 years of age, as
compared with 2 in 10 white teens.2-4 In addition
to the negative health and social consequences
borne by teenage mothers and their children, the
national financial burden is substantial. In 2010,
births involving teenage mothers cost the United
States nearly $10 billion in increased public assistance and health care and in income lost as a
result of lower educational attainment and reduced earnings among children born to teenage
mothers.5
The President’s Teen Pregnancy Prevention Initiative was launched in 2010 to address the high
teenage pregnancy rate by replicating evidencebased models and innovative strategies.6 Teenage pregnancy has also been designated by the
Centers for Disease Control and Prevention (CDC)
as one of the six Winnable Battles because of the
magnitude of the problem and the belief that it
can be addressed by strategies that are known to
be effective.7 The Winnable Battle target is to reduce the teenage birth rate by 20%, from 37.9
births per 1000 teens in 2009 to 30.3 per 1000
by 2015.
Long-acting, reversible contraceptive (LARC)
methods, which include intrauterine devices
(IUDs) and implants, have been shown to be acceptable to teens and young women, with higher
continuation rates than shorter-acting methods.8,9
LARC methods reduce the likelihood of pregnancy and of repeat pregnancy among adolescents,10,11 yet less than 5% of U.S. teens report
using LARC methods.12
Lack of information about effective contraception, limited access, and cost remain barriers to
the use of LARC methods by teens.13-15 It is unclear
whether removal of these barriers can reduce unintended pregnancy and birth rates among highrisk, sexually active teens. We assessed pregnancy, birth, and abortion rates in a cohort of teens
among whom these three barriers to highly effective reversible contraception were removed,
and we compared these rates with rates observed
nationally among all teens in the United States.
n engl j med 371;14

Me thods
Study Enrollment

The Contraceptive CHOICE Project was a prospective cohort study involving 9256 St. Louis area
girls and women 14 to 45 years of age, in which
the use of LARC methods was promoted to reduce unintended pregnancy.16 Participants were
recruited through referral from medical providers,
word of mouth, and study flyers. The Washington University School of Medicine in St. Louis
Human Research Protection Office approved the
study protocol before recruitment began, and all
participants provided written informed consent.
Participants 14 to 17 years of age provided written assent, and a parent or guardian provided
written consent. Minors could enroll under a
waiver of parental consent if they did not know
the whereabouts of their parents or guardians or
if they did not want their parents or guardians
to know that they were seeking contraception.
We enrolled four minors using the waiver.
Women and adolescent girls were eligible to
participate in CHOICE if they were English-speaking or Spanish-speaking, resided in the St. Louis
region or sought contraceptive services in selected
community clinics, had no desire for pregnancy for
at least 12 months, were sexually active or planning to be sexually active with a male partner during the next 6 months, and were not using a contraceptive method or were willing to switch to a
new, reversible contraceptive method. Women and
adolescent girls were ineligible if they had undergone a hysterectomy or sterilization procedure.

A Quick Take
animation is
available at
NEJM.org

Study Design

CHOICE provided standardized contraceptive
counseling to study participants regarding commonly used reversible contraceptive methods.17
Methods were presented in order from most to
least effective, and the potential side effects,
risks, and benefits of each method were reviewed.
Participants were provided with their chosen
method at their enrollment session in accordance with evidence-based clinical guidelines.18,19
If medical contraindications did not allow for
same-day insertion of a LARC device (e.g., if pregnancy could not be ruled out definitively or if the
participant had active cervicitis), participants received a shorter-acting method, such as oral contraceptive pills or depot medroxyprogesterone
acetate (DMPA) injection, until their chosen meth-
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od could be initiated. During the enrollment session, study staff performed a baseline interview,
and participants were screened for sexually transmitted infections.
Participants were followed for 2 to 3 years,
depending on their enrollment date. Telephone
interviews were administered by study staff at
3 and 6 months and every 6 months thereafter.
Participants received a $10 gift card after every
completed follow-up survey. During the baseline
and follow-up surveys, we collected detailed information regarding demographic characteristics
and reproductive history, including contraceptive
method use and satisfaction, sexual behavior,
and pregnancy.
This analysis involves the 1404 adolescents
who enrolled in CHOICE between 14 and 19 years
of age, from 2007 through 2011; 716 teens were
followed for 3 years, and 688 teens were followed
for 2 years. At each follow-up survey, we asked
participants if they had had a pregnancy. Participants who contacted study staff outside a
scheduled survey or came to the clinic with concerns about possible pregnancy completed a urine
pregnancy test. We recorded all pregnancies in a
pregnancy log and documented the contraceptive
method used at the time of conception. If the
outcome of the pregnancy was known at the time
of the survey (e.g., birth, miscarriage, or abortion),
it was documented in the pregnancy log. If a participant was currently pregnant, we subsequently
contacted her to record the pregnancy outcome.
Study Outcomes

The primary outcomes of the study were the rates
of pregnancy, live birth, and induced abortion
observed among participants who were 15 to 19
years of age at any time during study participation. We compared the rates in the CHOICE cohort with the most recent available rates among
all U.S. teens 15 to 19 years of age, from 2010,1
and hypothesized that the rates in CHOICE
would be lower than the national rates. Because
the U.S. rates represent all teenage girls and
women 15 to 19 years of age, including those
who are and those who are not sexually experienced, we also compared the CHOICE rates with
the national rates reported among sexually experienced teenage girls and women in 2008 (the
most recent available data).20 In addition, we examined rates according to age and race as secondary outcomes. All analyses of rates of pregnancy,
1318
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live birth, and induced abortion; teen-years of use
of contraceptive methods; and failure rates of contraceptive methods included data collected when
members of the cohort were 15 to 19 years of age.
Statistical Analysis

We used frequencies, percentages, medians, and
ranges to describe the demographic and reproductive characteristics of the participants at the
time of study enrollment. A chi-square test was
performed for categorical data, and a Wilcoxon
two-sample test was performed for continuous
data that was not normally distributed.
For this analysis, we calculated annual means
and 95% confidence intervals for rates of pregnancy, live birth, and induced abortion from 2008
through 2013, because the number of pregnancies and pregnancy outcomes that occurred among
teenage CHOICE participants each year was small.
Each rate represents the total number of events
(i.e., pregnancy, birth, or abortion) that occurred
among the participants divided by the total
amount of time contributed from 2008 through
2013. For a pregnancy to be considered in the
analysis, the outcome of the pregnancy (i.e., birth
or abortion, for the purposes of this study) had
to occur before 20 years of age. This is the same
approach used by the National Center for Health
Statistics in calculating U.S. rates.1 We calculated the time contributed by each participant during which she was not pregnant. If at the last
survey the participant reported she had not been
pregnant since the previous contact, we subtracted 6 weeks of contributed time to account for the
possibility of an early-stage and unknown pregnancy. For a participant who had a pregnancy,
we subtracted the total time she was pregnant
plus 1 month if she delivered, to account for postpartum infecundity. For participants who were
lost to follow-up, the last date of contact was the
cutoff point for outcomes and contributed time.
All analyses were performed with the use of
Stata software, version 11 (StataCorp).

R e sult s
Characteristics of the Participants

Table 1 gives the baseline demographic and reproductive characteristics of the 1404 teenage
participants, stratified by age group at enrollment
(14 to 17 years vs. 18 to 19 years). Nearly 500
minors 14 to 17 years of age were enrolled in the
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Table 1. Baseline Characteristics of Study Participants Overall and According to Age Group.
Total Cohort
(N = 1404)

Characteristic

14–17 Years
of Age
(N = 484)

18–19 Years
of Age
(N = 920)

Race — no. (%)†

P Value*
<0.01

Black

877 (62.5)

328 (67.8)

549 (59.7)

White

416 (29.6)

119 (24.6)

297 (32.3)

Other
Low socioeconomic status — no. (%)‡

111 (7.9)

37 (7.6)

74 (8.0)

623 (44.4)

163 (33.7)

460 (50.0)

Health insurance — no./total no. (%)

<0.01
<0.01

None

392/1361 (28.8)

78/453 (17.2)

314/908 (34.6)

Private

583/1361 (42.8)

218/453 (48.1)

365/908 (40.2)

Public

386/1361 (28.4)

157/453 (34.7)

229/908 (59.3)

2.0 (0–30)

3.0 (0–175)

Lifetime male sex partners — median no. (range)

3.0 (0–175)

Parity — no. (%)

<0.01
<0.01

0

1059 (75.4)

397 (82.0)

662 (72.0)

1

289 (20.6)

79 (16.3)

210 (22.8)

≥2

56 (4.0)

8 (1.7)

48 (5.2)

Previous unintended pregnancy — no./total no. (%)

671/1403 (47.8)

219/484 (45.2)

History of abortion — no. (%)

259 (18.4)

70 (14.5)

452/919 (49.2)
189 (20.5)

<0.01

History of sexually transmitted infection — no. (%)§

331 (23.6)

88 (18.2)

243 (26.4)

<0.01

Baseline chosen contraceptive method — no. (%)¶

0.16

<0.01

Hormonal IUD
Nonhormonal IUD
Etonogestrel implant

445 (31.7)

119 (24.6)

75 (5.3)

14 (2.9)

326 (35.4)
61 (6.6)

485 (34.5)

242 (50.0)

243 (26.4)

DMPA injection

127 (9.0)

51 (10.5)

76 (8.3)

Oral contraceptive pill

175 (12.5)

39 (8.1)

136 (14.8)

Ring

69 (4.9)

11 (2.3)

58 (6.3)

Patch

28 (2.0)

8 (1.7)

20 (2.2)

*	P values are for the comparison between the age groups (14 to 17 vs. 18 to 19 years of age).
†	Race was self-reported.
‡	Participants were classified as having low socioeconomic status if they reported current receipt of food stamps; vouchers from the Special
Supplemental Nutrition Program for Women, Infants, and Children; other welfare benefits; unemployment benefits; or difficulty in paying
for transportation, housing, health or medical care, or food.
§	Data are based on a self-reported history of chlamydia infection, gonorrhea, or trichomoniasis.
¶	DMPA denotes depot medroxyprogesterone acetate, and IUD intrauterine device.

study. Nearly half the participants reported a
previous unintended pregnancy, and 18% had a
history of abortion. As compared with younger
teens, those who were 18 to 19 years of age reported more lifetime male sex partners and greater
parity and had a higher frequency of previous
sexually transmitted infections. The majority of
teens in both age groups chose LARC methods,
but teens 14 to 17 years of age were more likely
than older teens to do so (77.5% vs. 68.4%, P<0.001).
The implant was the most common contraceptive
n engl j med 371;14

choice for participants 14 to 17 years of age,
whereas an IUD was most commonly chosen by
older teens (Table 1).
Pregnancy, Birth, and Abortion Rates

The 12-month, 24-month, and 36-month followup rates among CHOICE participants were 92%,
82%, and 75%, respectively. During 1738 teenyears of follow-up between 2008 and 2013, teens
in the CHOICE cohort reported 56 pregnancies,
32 births, 16 induced abortions, 7 miscarriages,
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as compared with 2008 U.S. rates representing
only sexually experienced teens. The pregnancy,
birth, and abortion rates per 1000 sexually experienced U.S. teens in 2008 were 158.5, 94.0, and
U.S. Population,
U.S. Population,
CHOICE
41.5, respectively.
Outcome
All Teens*
Sexually Experienced Teens†
Cohort‡
Figure 1 shows the pregnancy, birth, and abormean no. per
tion rates among CHOICE participants, as com1000 teens
pared with the 2010 rates among all U.S. teens.
no. per 1000 teens
(95% CI)
The rates were stratified according to age group
Pregnancy
57.4
158.5
34.0 (25.7–44.1)
and race. For all three outcomes within each
Birth
34.4
94.0
19.4 (13.3–27.4)
stratum, the rates among CHOICE participants
Abortion
14.7
41.5
9.7 (5.6–15.8)
were lower than the U.S. rates. The difference
between rates in CHOICE and national rates was
*	Data are U.S. rates for the year 2010.1
greater for those 18 to 19 years of age and
†	Data are U.S. rates for the year 2008.20
among black teens. Figure 2 shows the pregnancy
‡	Data are the mean annual rates for the years 2008 through 2013. CI denotes
confidence interval.
rates among CHOICE teens, as compared with
sexually experienced U.S. teens, according to age
group and race. For both age groups and both
and 1 stillbirth. Reported methods used at the races, the CHOICE rates were substantially lower
time of conception included the levonorgestrel than the national rates.
IUD (2 participants), DMPA injection (1), oral contraceptive pills (13), the ring (4), the patch (2),
Discussion
condoms (9), and no method (25). The teenyears of use and failure rates of contraceptive We found that pregnancy, birth, and abortion rates
methods among the participants using these were low among teenage girls and women enmethods were as follows: 394.2 teen-years and rolled in a project that removed financial and
5.1 failures per 1000 teen-years for the levonor access barriers to contraception and informed
gestrel IUD, 193.8 teen-years and 5.2 failures per them about the particular efficacy of LARC meth1000 teen-years for DMPA injection, 229.0 teen- ods. The observed rates of pregnancy, birth, and
years and 56.8 failures per 1000 teen-years for abortion were substantially lower than national
oral contraceptive pills, 77.2 teen-years and 51.8 rates among all U.S. teens, particularly when
failures per 1000 teen-years for the contraceptive compared with sexually experienced U.S. teens.
ring, and 32.9 teen-years and 60.8 failures per Stratification according to factors known to be
1000 teen-years for the contraceptive patch. No associated with sexual behavior and pregnancy
pregnancies occurred with the copper IUD (57.3 risk (age and race)21 showed that this was true
teen-years) or the etonogestrel subdermal implant among both older teens (18 to 19 years of age) and
(633.3 teen-years).
younger teens, as well as among both white
Table 2 gives the overall rates of pregnancy, and black teens.
live birth, and induced abortion in the CHOICE
The CDC Winnable Battle 2015 goal for teenteenage cohort; respective rates for teens in the age births is 30.3 per 1000 teens. The mean
United States in 2010 are provided for compari- annual teenage birth rate in our cohort was 19.4
son. The mean annual rates were 34.0 per 1000 per 1000 teens, 36% lower than the 2015 goal.
teens (95% confidence interval [CI], 25.7 to 44.1), Our teenage pregnancy and birth rates reflect
19.4 per 1000 (95% CI, 13.3 to 27.4), and 9.7 per teens using highly effective contraception, with
1000 (95% CI, 5.6 to 15.8), respectively. The cor- a high rate of LARC use in this cohort (i.e., 72%
responding 2010 rates among U.S. teens nation- overall among teens). Although the rate of LARC
ally were 57.4, 34.4, and 14.7 per 1000.
use among teens 15 to 19 years of age in the
Among teenage girls and women enrolled in United States has increased from less than 1% in
CHOICE, 97% were sexually experienced at base- 2002 to almost 5% in 2009, our study suggests
line, and 99% were sexually experienced by 12 that it is possible to achieve a much greater rate
months of follow-up. Thus, Table 2 also presents of use.12 Furthermore, teens in our cohort cona comparison of the mean annual rates in CHOICE tinued to use LARC methods longer than shortTable 2. Pregnancy, Birth, and Abortion Rates among Girls and Women 15
to 19 Years of Age in the CHOICE Cohort as Compared with Those in the
U.S. Population.*
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Abortions
(no. per 1000 teens)

Births
(no. per 1000 teens)

Pregnancies
(no. per 1000 teens)

er-acting methods such as the oral contraceptive
U.S.
CHOICE
pill and DMPA injection; two thirds of teens in
CHOICE were still using their LARC method at A Pregnancy Rate
120
120
24 months of follow-up, as compared with only
99.5
one third of teens using a non-LARC method.8
96.2
100
100
The limitations of our study must be consid80
80
ered. First, information about pregnancy was
self-reported by participants, and thus it is pos60
60
sible that the number of teenage pregnancies
40.1
37.8
40
40
was underestimated in the CHOICE cohort. The
31.8
30.1
26.9
20.9
U.S. pregnancy statistics rely on a composite of
20
20
birth data, the abortion surveillance system, and
0
0
self-reporting to estimate pregnancy rates. SecWhite
Black
15–17
18–19
ond, teens were surveyed on a regular basis reAge
Group
(yr)
Race
garding their contraceptive method use, which
may have influenced adherence to their contra- B Birth Rate
ceptive method. Third, the generalizability of our
120
120
results is uncertain. Teens in CHOICE received
100
100
standardized contraceptive counseling during
which methods were presented in order from
80
80
most to least effective. This counseling approach
58.5
60
may differ from the usual counseling that teens
60
51.4
receive in the United States but could certainly
40
40
be applied in routine practice. Fourth, the enroll23.6
23.1
19.6
17.4
ment of minors in CHOICE required parental
20
20
11.2
11.4
consent. Most teens can access confidential con0
0
traceptive services without parental notification
15–17
18–19
White
Black
or consent, regardless of age. Minors who enAge Group (yr)
Race
rolled in CHOICE with the consent of their parent or guardian may represent a group of teens C Abortion Rate
at lower risk for contraceptive nonuse and preg120
120
nancy.22 However, as compared with teens nation100
100
ally, the teens enrolled in CHOICE are at greater
risk for unintended pregnancy; 60% of the par80
80
ticipants are black (vs. 16% of female teens 15 to
23
60
19 years of age in the United States), and al60
most all had had sexual intercourse at the time
40
40
34.5
of enrollment, with nearly three quarters report23.7
ing sexual intercourse in the previous 30 days
20
20
11.6
9.4
8.4 5.7
8.5
4.5
(vs. national frequencies of 43% and one quarter,
21
0
0
respectively).
White
Black
15–17
18–19
A final limitation is that we compared a mean
Age Group (yr)
Race
annual rate for the period from 2008 through
2013 with 2010 national rates. From 2008 to
Figure 1. Pregnancy, Birth, and Abortion Rates among U.S. Teenage Girls
2010, the pregnancy rate declined by 15% among
and Women, as Compared with CHOICE Participants, Stratified According
all teens in the United States. The most recent
to Age and Race.
birth data (2012) indicate that the birth rate
among teens 15 to 19 years of age dropped to
29.4 per 1000, the lowest rate ever reported for ductions observed in CHOICE are substantial
the United States.24 (Data on national pregnancy and of public health importance.
and abortion rates are not yet available beyond
In summary, we found that in a cohort of teen2010.) Even with this continued decline, the re- age girls and women for whom barriers to conn engl j med 371;14
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Pregnancies
(no. per 1000 teens)

U.S.

300

250

250

150

150

136.0

100
50
0

253.0

200

178.0

137.0

100
40.1

20.9
15–17

18–19

Age Group (yr)

50
0

31.8

26.9
White
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large percentage opted to use LARC methods.
The rates of pregnancy, birth, and abortion in
our cohort were below both the most recent corresponding national rates and the CDC Winnable
Battle 2015 goal.

CHOICE

300

200

n e w e ng l a n d j o u r na l

Black

Race

Figure 2. Pregnancy Rates among Sexually Experienced U.S. Teenage Girls
and Women, as Compared with CHOICE Participants, Stratified According
to Age and Race.
Data for the 2008 U.S. rates stratified according to age and race are from
K. Kost, Guttmacher Institute (personal communication).

traception (lack of knowledge, limited access,
and cost) are removed and the use of the most
effective contraceptive methods is encouraged, a
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